Table 1. Clinical Information of Cirrhotic and Hepatocellular Carcinoma Patient Groupsa.
| Clinical information | Cirrhosis | HCC |
|---|---|---|
| Subjects (n) | 20 | 20 |
| Hepatitis C (n) | 8 | 13 |
| Hepatitis B (n) | 1 | 3 |
| Alcohol related (n) | 8 | 8 |
| Fatty liver (n) | 5 | 2 |
| Portal hypertension (n) | 3 | 0 |
| Diabetes (n) | 6 | 6 |
| Hypertension (n) | 5 | 7 |
| Cirrhosis present (n) | 20 | 16 |
| Age (years) | 56 ± 13 | 67 ± 11 |
| Alkaline phosphatase (IU/L) | 98 ± 42 | 144 ± 51 |
| Alanine aminotransferase (IU/L) | 30 ± 22 | 59 ± 68 |
| Aspartate aminotransferase (IU/L) | 39 ± 17 | 91 ± 68 |
| Bilirubin (mg/dL) | 1.56 ± 2.18 | 1.81 ± 1.45 |
| Albumin (g/dL) | 3.9 ± 0.5 | 3.5 ± 0.7 |
| Total protein (g/dL) | 7.1 ± 0.7 | 7.3 ± 0.8 |
| International normalized ratio | 1.2 ± 0.2 | 1.2 ± 0.3 |
| Platelet count (platelets/nL) | 100 ± 40 | 141 ± 99 |
| Creatinine (mg/dL) | 0.78 ± 0.24 | 0.84 ± 0.19 |
| AFP average (ng/mL) | 17 ± 41 | 327.25 ± 1150 |
| Female (n) | 10 | 7 |
| Male (n) | 10 | 13 |
a
Values represent either number of patients (n) or averaged clinical values plus or minus one standard deviation.